PTC Therapeutics (PTCT) Earnings Date, Estimates & Call Transcripts $47.01 +1.93 (+4.28%) As of 12:51 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PTC Therapeutics Earnings Summary Upcoming Q4 Earnings DateApr. 24After Market ClosesEstimatedConsensus EPS (Nov. 7) -$1.54 Actual EPS (Nov. 7) -$1.39 Beat By $0.15 Actual Revenue (Nov. 7) $196.79MPTC Therapeutics issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$1.39, which beat analysts' consensus estimates of -$1.54 by $0.15. Quarterly revenue was reported to be $196.79 million, above analyst estimates of $173.51 million. With a trailing EPS of -$4.73, PTC Therapeutics' earnings are expected to decrease next year, from ($4.52) to ($4.69) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)PTCT Upcoming EarningsPTC Therapeutics' Q1 2025 earnings is scheduled for Thursday, April 24, 2025, with a conference call scheduled on Wednesday, April 23, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get PTC Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PTC Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPTCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PTCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads PTC Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.55-$1.52-$1.54Q2 20252-$1.40-$1.36-$1.38Q3 20252-$1.22-$0.97-$1.10Q4 20252-$1.03-$0.69-$0.86FY 20258-$5.20-$4.54-$4.87Q1 20261-$0.57-$0.57-$0.57Q2 20261-$0.49-$0.49-$0.49Q3 20261-$0.37-$0.37-$0.37Q4 20261-$0.13-$0.13-$0.13FY 20264($1.56)($1.56)($1.56) Remove Ads PTC Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/24/2025(Estimated)--------11/7/2024Q3 2024-$1.54-$1.39+$0.15-$1.39$173.51M$196.79M8/8/2024Q2 2024-$1.00-$1.16 -$0.16-$1.03$192.12M$186.70M4/25/2024Q1 2024-$1.21-$1.20+$0.01-$1.20$160.27M$210.12M2/29/2024Q4 2023$0.29-$0.24 -$0.53$1.58$315.90M$307.06M10/26/2023Q3 2023-$0.85-$1.76 -$0.91-$1.76$210.23M$196.60M8/3/2023Q2 2023-$1.58-$2.66 -$1.08-$2.66$206.99M$213.80M4/27/2023Q1 2023-$1.64-$1.88 -$0.24-$1.88$200.48M$220.38M PTC Therapeutics Earnings - Frequently Asked Questions When is PTC Therapeutics's earnings date? PTC Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on PTCT's earnings history. What guidance has PTC Therapeutics issued on next quarter's earnings? PTC Therapeutics updated its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $600.0 million-$800.0 million, compared to the consensus revenue estimate of $891.2 million. Did PTC Therapeutics beat their earnings estimates last quarter? In the previous quarter, PTC Therapeutics (NASDAQ:PTCT) reported ($1.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.54) by $0.15. Learn more on analysts' earnings estimate vs. PTCT's actual earnings. How can I listen to PTC Therapeutics's earnings conference call? The conference call for PTC Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read PTC Therapeutics's conference call transcript? The conference call transcript for PTC Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded annual revenue of $806.78 million. How much profit does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded net income of -$626.60 million. PTCT has generated -$4.73 earnings per share over the last four quarters. What is PTC Therapeutics's EPS forecast for next year? PTC Therapeutics's earnings are expected to decrease from ($4.52) per share to ($4.69) per share in the next year. More Earnings Resources from MarketBeat Related Companies SMMT Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results VTRS Earnings Results QGEN Earnings Results ASND Earnings Results ROIV Earnings Results LNTH Earnings Results TGTX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:PTCT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PTC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTCT Stock Free PTCT Stock Alerts